Algert Global LLC Has $6.40 Million Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Algert Global LLC increased its holdings in Intuitive Surgical, Inc. by 48.1% in Q1, now owning 12,926 shares valued at approximately $6.40 million.
• A significant portion, specifically 83.64% of Intuitive Surgical's stock, is currently owned by institutional investors and hedge funds.
• Intuitive Surgical reported $2.19 EPS for the last quarter, exceeding analysts' expectations, and achieved a 21.4% revenue increase year-over-year.

Algert Global LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 48.1% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,926 shares of the medical equipment provider's stock after buying an additional 4,199 shares during the period. Algert Global LLC's holdings in Intuitive Surgical were worth $6,402,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of ISRG. Brighton Jones LLC increased its holdings in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG increased its holdings in Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after purchasing an additional 883 shares during the period. Commerce Bank increased its holdings in Intuitive Surgical by 1.3% in the fourth quarter. Commerce Bank now owns 15,610 shares of the medical equipment provider's stock valued at $8,148,000 after purchasing an additional 199 shares during the period. BI Asset Management Fondsmaeglerselskab A S increased its holdings in Intuitive Surgical by 71.1% in the fourth quarter. BI Asset Management Fondsmaeglerselskab A S now owns 38,537 shares of the medical equipment provider's stock valued at $20,115,000 after purchasing an additional 16,020 shares during the period. Finally, MML Investors Services LLC increased its holdings in Intuitive Surgical by 0.4% in the fourth quarter. MML Investors Services LLC now owns 63,181 shares of the medical equipment provider's stock valued at $32,978,000 after purchasing an additional 228 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock valued at $7,896,972 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ISRG. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Robert W. Baird decreased their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Wells Fargo & Company increased their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. BTIG Research increased their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price objective for the company from $515.00 to $440.00 in a report on Monday, June 9th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Price Performance

ISRG stock opened at $480.26 on Monday. The stock has a market capitalization of $172.16 billion, a PE ratio of 66.98, a price-to-earnings-growth ratio of 5.03 and a beta of 1.59. The company's 50-day moving average is $508.75 and its 200-day moving average is $524.77. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.78 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.